Ongoing CBD review by the U.S. Food and Drug Administration shouldn’t mean that CBD makers can’t face labeling lawsuits, a federal judge in Florida ruled. The ruling means that Diamond CBD of Fort Lauderdale cannot await FDA guidelines before facing a 2019 allegation that it misrepresented the amount of CBD in its products. U.S. District Judge […]
Florida judge: FDA’s CBD review shouldn’t stop labeling claims is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs